Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.65
Delayed Data
As of Mar 02
 0.00 / 0.00%
Today’s Change
3.10
Today|||52-Week Range
7.84
-12.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues8.0M76.9M14.0M7.9M
 
 
 
 
 
Cost of Goods Sold0.00--499.0K624.0K
 
 
 
Depreciation And Amortization2.9M2.1M1.3M939.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.1M--12.2M6.3M
 
 
 
 
General Expenses74.7M72.0M47.7M47.0M
 
 
 
 
 
Other Operating Expenses241.0K405.0K0.000.00
 
 
 
Research And Development51.9M53.8M33.0M34.1M
 
 
 
 
 
Total Operating Expenses77.8M74.5M49.5M48.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-69.9M2.5M-35.5M-40.7M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.3M
 
 
Other Expenses0.007.9M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-69.8M10.4M-35.4M-42.9M
 
 
 
 
 
Income Taxes-95.0K0.000.00-362.0K
 
 
 
Net Income-69.7M10.4M-35.4M-42.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.6M33.4M34.8M55.8M
 
 
 
 
 
Shares To Calculate EPS Diluted32.6M33.5M34.8M55.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.14$0.31-$1.02-$0.76
 
 
 
 
 
EPS Diluted-$2.14$0.31-$1.02-$0.76
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account